Hematuria-Nephropathy-Deafness Syndrome
1 clinical trials · Condition
◉ Watch Hematuria-Nephropathy-Deafness Syndrome
| Record | Firm | Date |
|---|---|---|
| Biomarker for Alport Syndrome (BioAlport) (NCT02718027) | CENTOGENE GmbH Rostock | 2018-08-20 |
Track Hematuria-Nephropathy-Deafness Syndrome automatically
Every clearance here is in the API, with alerts when new ones post.